PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells
Journal of Biological Chemistry · 2024-06 · 300 (6) · 107312
DOI: 10.1016/j.jbc.2024.107312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-06. Verfasst von Qunsong Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory for Genome Stability & Disease Prevention and Carson International Cancer Center, Marshall Laboratory of Biomedical Engineer…. Hauptthemen laut MEDLINE: BRCA1 Protein, DNA Replication. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Homologous-recombination deficiency due to breast cancer 1/2 (BRCA1/2) mutations or mimicking BRCA1/2 mutations confer synthetic lethality with poly-(ADP)-ribose polymerase 1/2 inhibitors. The chromatin regulator Pax2 transactivation domain interacting protein (PTIP) promotes stalled replication fork degradation in BRCA1-deficient cells, but the underlying mechanism by which PTIP regulates stalled replication fork stability is unclear. Here, we performed a series of in vitro analyses to dissect the function of UFMylation in regulating fork stabilization in BRCA1-deficient cells. By denaturing co-immunoprecipitation, we first found that replication stress can induce PTIP UFMylation. Interestingly, this post-translational modification promotes end resection and degradation of nascent DNA at stalled replication forks in BRCA1-deficient cells. By cell viability assay, we found that PTIP-depleted and UFL1-depleted BRCA1 knockdown cells are less sensitive to poly-(ADP)-ribose polymerase inhibitors than the siRNA targeting negative control BRCA1-deficient cells. These results identify a new mechanism by which PTIP UFMylation confers chemoresistance in BRCA1-deficient cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory for Genome Stability & Disease Prevention and Carson International Cancer Center, Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China; Guangdong Ke…
- Guangdong Key Laboratory for Genome Stability & Disease Prevention and Carson International Cancer Center, Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China. Electronic a…
Förderung
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Tan, Q., & Xu, X. (2024). PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells. Journal of Biological Chemistry, 300(6), 107312. https://doi.org/10.1016/j.jbc.2024.107312
Vancouver
Tan Q, Xu X. PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells. Journal of Biological Chemistry. 2024;300(6):107312. doi:10.1016/j.jbc.2024.107312
BibTeX
@article{Tan2024,
author = {Tan, Qunsong and Xu, Xingzhi},
title = {PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {6},
pages = {107312},
doi = {10.1016/j.jbc.2024.107312}
}
EUVIMED